 CAMBRIDGE, Mass., July 19, 2021 GLOBE NEWSWIRE -- Sigilon Therapeutics, Inc. NASDAQ:SGTX, a biotechnology company that seeks to develop functional cures for chronic diseases through its Shielded Living TherapeuticsTM platform, today announced the appointment of Ajay Rai, M.B.A., as Senior Vice President, Head of Business Development. Most recently, Mr. Rai served as Vice President, Corporate Development, Strategy Alliance Management at Frequency Therapeutics where he was responsible for evolving the companys overall business and corporate strategy and played an integral role in executing several financing rounds, including an Initial Public Offering. 